Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis

BackgroundSevere eosinophilic asthma (SEA) in the presence of chronic rhinosinusitis with nasal polyps (CRSwNP) indicates the presence of a more extensive eosinophilic inflammation. Post-hoc analyses from a pivotal clinical trial have demonstrated the enhanced efficacy of benralizumab on asthma outc...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Maria D'Amato, Francesco Menzella, Elena Altieri, Elena Bargagli, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Fausto De Michele, Fabiano Di Marco, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Alessandra Vultaggio, Alessandra Ori, Lucia Simoni, Silvia Boarino, Gianfranco Vitiello, Maria Aliani, Stefano Del Giacco
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Frontiers Media S.A. 2022-05-01
Serie:	Frontiers in Allergy
Ämnen:	severe eosinophilic asthma chronic rhinosinusitis with nasal polyps benralizumab observational biologics
Länkar:	https://www.frontiersin.org/articles/10.3389/falgy.2022.881218/full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!